01 1Hangzhou Zhongmei Huadong Pharmaceutical
01 1TACROLIMUS USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-21
Pay. Date : 2016-12-29
DMF Number : 31225
Submission : 2016-12-03
Status : Active
Type : II
20
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TACROLIMUS USP, with a corresponding US DMF Number 31225.
Remarkably, this DMF maintains an Active status since its submission on December 03, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 21, 2017, and payment made on December 29, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
